Latest Coloplast News & Updates

See the latest news and media coverage for Coloplast. We track all announcements, press releases, and industry mentions in real time, all in one place.

Coloplast

Intimate healthcare solutions provider

coloplast.com

Headquarters: Humlebæk, Denmark
Company type: Public company
Number of employees: 10,000+

Last updated Today

Latest news about Coloplast

In short: Coloplast appointed Gavin Wood as CEO, expanded its production capacity in Portugal, and received FDA approval for a new penile prosthesis.

Company announcements

June 3 Coloplast

Coloplast's Titan Prime inflatable penile prosthesis approved by FDA

The next-generation device will be available in the U.S. in late 2026, helping millions of men with erectile dysfunction.

May 12 Coloplast

Coloplast announces Q2 results with 6% organic growth

The company also reported 6% EBIT growth in constant currencies, reflecting increased product usage

May 4 Coloplast

Coloplast introduces Gavin Wood as new President & CEO

He shares in a video what attracted him to Coloplast and excites him about the future. Welcome, Gavin!

May 1 Coloplast

Coloplast wins Vizient contract for Biatain Silicone Fit

The dressing's 3DFit Technology adapts to wound depth up to 2 cm, supports pressure injury prevention, allows inspection and reapplication, and may reduce waste and improve efficiency.

Media coverage

June 16 Markets Daily

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update - Markets Daily

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) saw a large decrease in short interest in the month of May. As of May 29th...

June 3 Euroinvestor

MT Højgaard got a hard price beating, while Coloplast made a small price jump: That's how the trading day went

Danish stocks came under pressure after there were new attacks between Iran and the US, which has led investors to question whether...

June 3 Børsen

Coloplast receives approval for new penis implant in USA

Coloplast's next generation of inflatable penile implants, Titan Prime, has been approved by the U.S. health authorities. This appears from a...

May 20 Yahoo Finance

Kepler Cheuvreux starts Coloplast as “buy,” says de-rating overdone

Kepler Cheuvreux initiated coverage of Danish medtech company Coloplast with a “buy” rating and a target price of DKK482.

Never miss news about Coloplast

Track Coloplast and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Coloplast competitors & trending companies

Browse news for competitors to Coloplast and other trending companies.